Accession PRJCA001124
Title Chinese Prostate Cancer Genome and Epigenome Atlas
Relevance Medical
Data types Whole genome sequencing
Organisms Homo sapiens
Description Chinese Prostate Cancer Genome and Epigenome Atlas, CPGEA, is the largest and most comprehensive cancer genomics study conducted in China. Our genome and epigenome roadmap of prostate cancer for Chinese men is consisted of over 1200 genomic datasets from more than 200 pairs of match normal and primary prostate cancers, providing an invaluable resource and opportunity to complement and compare to previous cancer genomics studies represented by TCGA.
Sample scope Multiisolate
Release date 2018-11-16
PubMed ID Article title Journal name DOI Year
32238934 A genomic and epigenomic atlas of prostate cancer in Asian populations Nature 10.1038/s41586-020-2135-x 2020
33414463 KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer Cell Death & Disease 10.1038/s41419-020-03354-4 2021
Agency program Grant ID Grant title
Zhangjiang National Innovation Demonstration Zone Province N/A the "Zhangjiang National Innovation Demonstration Zone" Initiative Development Fund
Ministry of Science and Technology of the People's Republic of China (MOST) 2016YFC0902200 Key Research and Development Project on Precision Medicine
Shanghai 14DZ2272300 the Shanghai Key Laboratory of Cell Engineering
Shanghai 2017ZZ01005 Top Priority Medical Center Project
13th Five-Year Plan 2017ZX093040300002 National Major New Drug Discovery Initiative
National Natural Science Foundation of China (NSFC) 81602467
Submitter Jing    Li  (
Organization Second Military Medical University
Submission date 2018-11-16

Project Data

Resource name Description